Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells.

ABSTRACT:

SUBMITTER: Fan Y 

PROVIDER: S-EPMC9421358 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature